fda tirzepatide weight loss Lilly Rises on Approval of Weight-Loss Drug Zepbound for Sleep Apnea 3 months vs. 6 months

It belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists, which help the body produce more insulin while providing glucose control in the liver

Gently swirl or tilt the bottle until the medication is mixed

While these synthetic GLP-1 agonists have demonstrated remarkable efficacy in clinical trials, they are associated with a range of side effects, including common gastrointestinal issues such as nausea, vomiting, diarrhea, and constipation, which are often dose-dependent (Kommu S et al., 2025

Peptide manufacturing is significantly more expensive than chemical manufacturing. Thats where Lilly may have the longer-term edge

This leads to a drop in pain-related signals traveling to the nervous system

For example, large cardiovascular outcome trials have shown reductions in major adverse cardiac events